All Insights Articles
A Prescription for Rebuilding Trust in the FDA
The FDA should recommit to transparent, evidence-based decision-making, apply its standards consistently, and modernize its regulatory systems, argue Yale SOM’s Jeffrey Sonnenfeld, Megan Ranney and Sten Vermund of the Yale School of Public Health, and Harvard neurologist Patricia Greenstein, with co-author Steven Tian.
When Essential Infrastructure Projects Involve Exceptional Risk, No Sector Can Go It Alone
At the World Bank’s Multilateral Investment Guarantee Agency, Laura Alonzo ’96 mobilizes private investment in the developing and conflict-wracked economies that need it most.
What Keeps Women Artists Out of the Art World’s Top Echelon?
Women remain underrepresented at the highest levels of the art world. We talked to Yale SOM’s Magnus Resch about his new study tracing the institutional pathways that shape artistic success.
What Critics Get Wrong About Dual-Class Shares
The SpaceX IPO has renewed debate over dual-class share structures, which give founders outsized voting power. Yale SOM’s Jeffrey Sonnenfeld and co-author Steven Tian argue that these structures can create long-term shareholder value under the right conditions.
You Probably Need a Mission Statement
Professor James Baron says a genuine mission statement can help organizations of all kinds cultivate thriving internal cultures and credibility in the outside world.
Leadership Lessons from a Lifetime Investing in Tech
Anne Glover ’78 traces her journey from shop-floor foreman to deep-tech investor and discusses the challenges facing the UK and Europe in building homegrown tech giants.
Inside the 25-Year Mission to Give India’s City Dwellers a Voice in Government
Drawing on his experience at Yale SOM, his career in finance, and his first encounter with a New England town meeting, Ramesh Ramanathan ’91 returned to India with his wife, Swati, to help citizens shape the future of their communities.
Mobilizing a System to Treat People with Sickle Cell Disease
Cece Calhoun ’21, medical director of Yale’s Sickle Cell Program, reflects on the challenges of building teams and structures to support patients facing both chronic illness and systemic inequities.
How Dr. Bronner’s Turned a Soap Company into a Blueprint for Regenerative Business
Darcy Shiber-Knowles ’13 has helped grow Dr. Bronner’s from a cult favorite to a force reshaping how industries think about sustainability.
Too Many Pro-Democracy Groups Are Weakening the Cause
Yale SOM’s Jeffrey Sonnenfeld argues that the proliferation of organizations fighting for democracy has divided resources, muddled messaging, and discouraged potential allies.
